☆ 4.4 Letter

Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance

HAEMATOLOGICA (2016)

Get Full Text
Add to Collection

Journal

HAEMATOLOGICA
Volume 101, Issue 8, Pages E339-E343

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2015.139667

Keywords

multiple myeloma; deratumumab; cell lysis; bone marrow stromal cell; sepantronium bromide; abrogation

Categories

Hematology

Funding

  1. Worldwide Cancer Research [14-1223] Funding Source: researchfish
  2. Worldwide Cancer Research [14-1223] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.